Experimental models of acute pancreatitis: Are they suitable for evaluating therapy?

International Journal of Colorectal Disease

Volumn 15, Issue 3, 2000, Pages 127-135

  Foitzik, T ^a   Hotz, H G ^a   Eibl, G ^a   Buhr, H J ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Acute pancreatitis; Animal models; Study design; Therapy

Indexed keywords

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DISEASE SIMULATION; EXPERIMENTAL ANIMAL; HUMAN; IN VITRO STUDY; MEDICAL RESEARCH; METHODOLOGY; MONITORING; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STANDARDIZATION;

ACUTE DISEASE; ANIMAL; CONTROLLED CLINICAL TRIALS; DISEASE MODELS, ANIMAL; HUMAN; MICE; PANCREATITIS; RATS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 0033834483     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840000216     Document Type: Review

References (95)

1. Treatment of acute pancreatitis. Comparison of animal and human studies
2. Clinical relevance of experimental acute pancreatitis
3. Experimentelle Therapieansatze bei akuter Pankreatitis
4. Underestimation of acute pancreatitis: Patients with only a small increase in amylase/lipase levels can also have or develop severe acute pancreatitis
5. A better model of acute pancreatitis for evaluating therapy
6. When should treatment of acute pancreatitis be started
7. The role of cytokines in the pathogenesis of acute pancreatitis
8. Trypsinogen activation peptides in experimental rat pancreatitis. Prognostic implications and and histopathologic correlates
9. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis
10. Standards in monitoring acute experimental pancreatitis
11. Sepsis and multiple organ dysfunction syndrome: A clinical-mechanistic overview
12. Systemic inflammatory response syndrome
13. Intestinal microcirculation and gut permeability in acute pancreatitis: Early changes and therapeutic implications
14. Experimental models and concepts in acute pancreatitis
15. Experimental models of pancreatitis
16. Experimental models of acute pancreatitis
17. Experimental animal models of acute pancreatitis
18. Experimental models of acute pancreatitis and their clinical relevance
19. Experimental models of the acute pancreatitis and their relevance to human disease
20. A review of experimental pancreatitis
21. Acute hemorrhagic pancreatitis (massive necrosis) with fat necrosis induced in mice by DL-ethionine fed with a choline-deficient diet
22. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue
23. Course and spontaneous regression of acute pancreatitis in the rat
24. Bemerkungen zu meiner Methode der experimentellen Erzeugung der akuten haemorrhagischen Pankreatitis
25. Gradations of pancreatitis, edematous, through hemorrhagic, experimentally produced by controlled injection of microspheres into blood vessels in dogs
26. Histology and bacteriology of closed duodenal loop models of experimental acute pancreatitis in the rat
27. Mechanisms of sepsis in acute pancreatitis in opossums
28. Pathogenesis of pancreatic edema following exocrine duct obstruction
29. Alterations in the pancreatic resistance to bile in the pathogenesis of acute pancreatitis
30. Experimental acute pancreatitis in rats after chronic and chronic plus acute ethanol administration in combination with a pancreatic juice edema
31. Transition of rat pancreatic juice edema into acute pancreatitis by single ethanol administration
32. Exocrine hyperstimulation but not pancreatic duct obstruction increases the susceptibility to alcohol-relate pancreatic injury
33. The influence of glucagon on acute experimental pancreatitis in the rat
34. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis
35. Morphometric characteristics and homogeneity of a new model of acute pancreatitis in the rat
36. Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis
37. Effect of fluid resuscitation with and without endothelin A receptor blockade on hemoconcentration and organ function in experimental pancreatitis
38. Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis
39. Time course of bacterial infection of the pancreas and its relation to disease severity in a rodent model of acute necrotizing pancreatitis
40. Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis
41. Bacterial contamination of pancreatic necrosis
42. The significance of bacterial infection in acute pancreatitis
43. Trypsinogen activation peptides in peritoneal fluid as predictors of late histopathological injury in necrotizing pancreatitis of the rat
44. Therapeutic effect of isovolemic hemodilution with dextran 60 on the impairment of pancreatic microcirculation in acute biliary pancreatitis
45. Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis
46. Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat
47. Identification of pancreas necrosis in severe acute pancreatitis: Imaging procedures versus clinical staging
48. Early detection of acute fulminant pancreatitis by contrast-enhanced computed tomography
49. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis
50. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem
51. Endothelin receptor blockade improves fluid sequenstration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis
52. Glutamine stabilizes intestinal permeability and reduces pancreatic infection in acute experimental pancreatitis
53. The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress
54. Effect of PAF antagonists on cerulein-induced pancreatitis
55. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist
56. Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats
57. In vivo rat pancreatic acinar cell function during supramaximal stimulation with caerulein
58. Supramaximal caerulein stimulation and ultrastructure of rat acinar cell: Early morphological changes during development of experimental pancreatitis
59. Caerulein induced acute necrotizing pancreatitis in mice: Protective effects of proglumide, benzotript, and secretin
60. Experimental production of pancreatitis with ethionine
61. Equal effectiveness of L and D ethionine in producing tissue damage in rats and mice
62. Acute experimental hemorrhagic-necrotizing pancreatitis induced by feeding a choline-deficient, ethionine-supplemented diet. Methodology and standards
63. Effects of short-term pancreatic duct obstruction in rats
64. Pancreatic duct obstruction in rabbits causes digestive zymogen and lysosomal enzyme colocalization
65. The role of biliary obstruction in the pathogenesis of acute pancreatitis in the opossum
66. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum
67. Duodenal reflux and the etiology of pancreatitis
68. Acute pancreatitis caused by closed duodenal loop in the rat
69. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis
70. Experimental pancreatitis in the rat: Role of bile reflux in sodium taurocholate-induced acute haemorrhagic pancreatitis
71. Pancreatic duct pressure, duct permeability and acute pancreatitis
72. The low-pressure duct perfusion model of acute pancreatitis
73. Experimental purpura and pancreatic necrosis produced by Forssman heterophil antibody
74. Foreign serum-induced pancreatitis in mice. I. A new model of acute pancreatitis
75. Pancreatic injury caused by intraductal injection of foreign serum in rat
76. Production of acute hemorrhagic pancreatitis in the dog using venom of scorpion, Buthus quinquestriatus
77. Studies on pancreatitis. II. Acute pancreatic necrosis produced experimentally by the Arthus sensitization reaction
78. Acute hemorrhagic necrosis produced by local Shwartzman reaction
79. Pancreatic lesions in shock and their significance
80. Contribution of pancreatic edema and short-term ischemia to experimental acute pancreatitis in the rat. Procedure and pathomorphological investigations
81. Injection of microspheres into pancreatic arteries causes acute hemorrhagic pancreatitis in the rat: A new animal model
82. Pancreatic venous stasis and endotoxaemia as aetiologic factors in acute haemorrhagic pancreatitis
83. The effect of dobutamine infusion on splanchnic blood flow and oxygen transport in patients with acute pancreatitis
84. Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green
85. Contrast-enhanced computed tomography and microangiography of the pancreas in acute human hemorrhagic/necrotizing pancreatitis
86. Pancreatic necrosis develops within 96 hours
87. Bacteriologic status of necrotic tissue in necrotizing pancreatitis
88. Microbiological findings in severe pancreatitis
89. Hemoconcentration as an early risk factor for necrotizing pancreatitis
90. Early increase in intestinal permeability in patients with severe acute pancreatitis: Correlation with endotoxemia, organ failure, and mortality
91. Infected necrosis: Morbidity and therapeutic consequences
92. Pancreatic infection complication acute pancreatitis
93. Incidence of necrotizing pancreatitis and factors related to mortality
94. Progress in acute pancreatitis
95. Early severe acute pancreatitis - A new subgroup